Thursday, Nov 30, 2023
×
Outlook.com
×

Lupin Launches Generic Contraceptive Drug In The US

Lupin Launches Generic Contraceptive Drug In The US

The Mumbai-based drugmaker has launched the product in the US market under an exclusive license, marketing, and distribution agreement with Slayback Pharma LLC

File Photo.
File Photo.

Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market.

The Mumbai-based drugmaker has launched the product in the US market under an exclusive license, marketing, and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in a statement.

Slayback had earlier launched this product in the US in February 2021.

Merzee (norethindrone acetate and Ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals' Taytulla capsules.

As per IQVIA MAT February 2022 data, Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had estimated annual sales of $90 million in the US. 

Advertisement
Advertisement
Advertisement
Advertisement